RadIal Versus Femoral InvEstigation in ST Elevation Acute Coronary Syndrome (RIFLE-STEACS)

February 5, 2012 updated by: Enrico Romagnoli, Policlinico Casilino ASL RMB

RadIal Versus Femoral Randomized InvEstigation in ST Elevation Acute Coronary Syndrome

Prospective, randomized, multi-center trial comparing the safety and efficacy in the prevention of net adverse clinical outcomes (NACE) of transfemoral vs. transradial approach for the treatment of patients with ST-elevation acute coronary syndrome (STEACS) undergoing primary angioplasty

Study Overview

Detailed Description

Prospective, randomized, double arm study. The study population will include all consecutive patients presenting with a ST-elevation Acute Coronary Syndrome and candidates for primary percutaneous coronary intervention, who agree and provide written informed consent for the study.

Before arterial stick for percutaneous access, patients will be randomized according to sealed numbered envelopes. Subsequently, arterial access will be obtained and the diagnostic/interventional procedure will be performed according to routine clinical practice, leaving ancillary medications, choice of devices and means of hemostasis at the physician's discretion.

In the randomization process all participating centers will be equally stratified to avoid statistical unbalance.

Study Type

Interventional

Enrollment (Actual)

1001

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Modena, Italy, 41124
        • Università di Modena e Reggio Emilia
      • Rome, Italy, 00100
        • Ospedale Sandro Pertini
      • Rome, Italy, 00100
        • Policlinico Casilino
      • Turin, Italy, 10100
        • University of Turin, San Giovanni Battista Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Subject is >18 years old with recent acute ST-elevation acute coronary syndrome (STEACS) requiring emergent coronary angiography.
  2. Patient has no contraindication to percutaneous arterial access by both and transfemoral route.
  3. Subject has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as approved by the Institutional Review Board/Ethics Committee of the respective clinical site.
  4. Patient and the treating physician agree that the subject will comply with all follow-up evaluations.

Exclusion Criteria:

  1. Subject's age is <18 years and he has no acute ST-elevation myocardial infarction (ST elevation of a least 0.1 mV in ≥2 extremity leads or at least 0.2 mV in ≥2 precordial leads).
  2. Subject has had a recent stroke or TIA (<4 weeks), irrespective of age.
  3. Patient has an international normalized ratio (INR) > 2.0, or other severe bleeding diathesis
  4. The patient is pregnant or breastfeeding.
  5. Known allergies to: aspirin, clopidogrel and ticlopidine, heparin, IIb/IIIa inhibitors, stainless steel, or contrast agent (which cannot be adequately premedicated).

7.Subject is currently participating in an investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the current study endpoints.

8.Prior participation in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Radial
group of patients undergoing primary angioplasty by transradial approach
diagnostic and interventional procedures by radial artery access
Other Names:
  • transradial
Active Comparator: Femoral
group of patients undergoing primary angioplasty by transfemoral approach
diagnostic and interventional procedures by femoral artery access
Other Names:
  • transfemoral

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Net Adverse Clinical Event
Time Frame: 30-day
Cumulative of cardiac death, myocardial infarction, target lesion revascularization, stroke and bleeding
30-day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Net Adverse Clinical Event
Time Frame: 1-year
Cumulative of cardiac death, myocardial infarction, target lesion revascularization, stroke and bleeding
1-year
Individual components of NACE
Time Frame: 30-day
Cardiac death, Myocardial infarction, Target Lesion revascularization, Stroke, Major Bleeding
30-day
Individual components of NACE
Time Frame: 1-year
Cardiac death, Myocardial infarction, Target Lesion revascularization, Stroke, Major Bleeding
1-year
Total procedural and fluoroscopy times for the index procedure
Time Frame: 1 day
Comparison of procedural and fluoroscopy times between the two study groups
1 day
Hospital stay
Time Frame: 30-day
Days of hospitalization
30-day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ernesto Lioy, MD, Policlinico Casilino

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2009

Primary Completion (Actual)

July 1, 2011

Study Completion (Anticipated)

July 1, 2012

Study Registration Dates

First Submitted

August 15, 2011

First Submitted That Met QC Criteria

August 18, 2011

First Posted (Estimate)

August 19, 2011

Study Record Updates

Last Update Posted (Estimate)

February 7, 2012

Last Update Submitted That Met QC Criteria

February 5, 2012

Last Verified

February 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Radial approach

Subscribe